APOB and metabolic dysfunction-associated steatotic liver disease: Therefore, the identification of APOB mutations in subjects with NAFLD-HCC would be to allow the diagnosis, in these cases mostly unrecognized, of familial hypobetalipoproteinemia in the first-degree relatives, allowing to establish adequate HCC surveillance.